|
|
Clinical Trial
|
|
Clinical Trial
Struggle shows obstacle 29 Jan 2006
...review concluded. Utley and Dillard said Bowles was offered the chance to get the drugs from a clinical trial but declined. "It ...
- Kansas.com,
Penn Study Identifies Patients Most at-Risk for Secondary Strokes 29 Jan 2006
..."Intracranial stenting has not been evaluated in a controlled clinical trial and the effectiveness of this approach remains in question," adds Dr. Kasner. ...
- DG News
Pooled Analysis Shows That Gemcitabine Plus Platinum Analogs ... 29 Jan 2006
SAN FRANCISCO, CA -- January 27, 2006 -- A pooled analysis of clinical trial results found a statistically significant survival advantage if patients with ...
- DG News
FDA Approves Exubera, First Inhalable Form Of Insulin For ... 29 Jan 2006
...sugar levels and not constantly worry about how I manage my diabetes," said Jamie Villastrigo, a type 2 diabetes patient and Exubera clinical trial participant ...
- Medical News Today (press release),
Going global 29 Jan 2006
2002. Nutley-based Hoffmann-La Roche Inc. is one of several US companies with Chinese clinical trial centers, the report said. The ...
- NorthJersey.com,
Mater Dei - a teaching hospital 29 Jan 2006
There are complaints from highly recognised clinical trial and research agencies, who are responsible to provide the funds and make the mundane arrangements ...
- Times of Malta,
Resolve to make change for the better in 2006 29 Jan 2006
...significantly. In one clinical trial, moderate physical activity reduced the risk of colon and rectal cancer by 50 percent. Imagine ...
- Battle Creek Enquirer,
Helping comfort pancreatic cancer patients 29 Jan 2006
Network. A PALS associate can also perform a personalized clinical trial search for you in the PALS database of clinical trials. ...
- Charlotte Observer,
Doctors progress in treatment of childhood cancer 29 Jan 2006
...to patient. "We have about a dozen targeted therapy drugs in clinical trial," said pediatric oncologist Dr. John Maris. Maris is ...
- Cherry Hill Courier Post,
A new identity 29 Jan 2006
Ambryx, which expects its first clinical trial this year for an anti-obesity pill, chose an office inside one of the many buildings that is carving out a new ...
- Press-Enterprise (subscription),
More time with a doctor, more tests -- and more money 29 Jan 2006
Even the Mayo Clinic, in Rochester, Minn., a leading research hospital, has been conducting a clinical trial that offers massage to patients recovering from ...
- Providence Journal (subscription),
Clinical Trial: Effect of Environmental Exposures on the Egg ... Jan 28, 2006
By Clinical Trial - US National Library of Medicine. Our data indicate that environmental exposure to the heavy metal lead are more ...
- Community Dispatch (press release)
Kosan starts clinical trial Jan 25, 2006
Inc. (KOSN), a company that makes anticancer drugs, began the first phase of a clinical trial for a heat shock protien inhibitor. ...
- San Jose Mercury News,
Corautus Genetics' Phase IIb Clinical Trial for Severe Angina ... Jan 26, 2006
GENASIS is Corautus' Phase IIb clinical trial to evaluate the safety and efficacy of its proprietary Vascular Endothelial Growth Factor-2 (VEGF-2) for the ...
- PharmaLive.com (press release),
Local heart attack patient participates in clinical trial Jan 26, 2006
Doctors at Mid Carolina Cardiology are treating the first heart attack patient in a clinical trial for what may be a groundbreaking drug. ...
- WCNC (subscription),
UTHCT debuts new diabetes drugs clinical trial Jan 24, 2006
A new diabetes drug that also lowers cholesterol and fatty acids in the blood is the subject of a new clinical trial at The University of Texas Health Center ...
- East Texas Review,
Proacta Inc Announces Phase I Clinical Trial of Novel Prodrug to ... Jan 24, 2006
Proacta Inc, an early stage biotechnology company, announced today that cancer patient treatment is underway in its Phase I study of PR-104, a hypoxia targeted ...
- Genetic Engineering News,
FDA relaxes clinical trial rules Jan 23, 2006
Recently the US Food and Drug Administration (FDA) unveiled a major revision to its clinical trials guidelines. The changes are ...
- myDNA.com,
New database to sharpen clinical trial designs Jan 24, 2006
24/01/2006 - Wolters Kluwer Health has launched the first database covering both ongoing and published global clinical trials in order to help pharma and ...
- OutSourcing-Pharma.com,
Clinical Trial Registration Arch Intern Med. 2006;166:150. Jan 23, 2006
Trials must be registered at or before the onset of patient enrollment. This policy applies to any clinical trial starting enrollment after March 1, 2006. ...
- Archives of Internal Medicine
Hepatitis C protease inhibitor does well in early clinical trial Jan 25, 2006
A hepatitis C virus protease inhibitor has done well in early clinical trials. The oral drug, VX-950, which is being developed by ...
- Aidsmap,
Clinical Data Initiates Pivotal Phase III Trial for Novel ... Jan 26, 2006
...pharmacogenomics to guide drug utilization, announced today that the Company will begin enrollment of a pivotal Phase III clinical trial for vilazodone, a ...
- PharmaLive.com (press release),
Kosan Initiates Phase I Clinical Trial of Oral Hsp90 Inhibitor KOS ... Jan 25, 2006
The Phase I clinical trial of oral KOS-1022 will evaluate the safety, pharmacokinetics, pharmacodynamics, and bioavailability of escalating doses of KOS-1022 ...
- PR Newswire (press release),
CONRAD Announces Results of Phase II Clinical Trial for Ushercell Jan 26, 2006
ARLINGTON, Va., Jan. 26, 2006 /PRNewswire/ -- CONRAD is pleased to announce the results of the Phase II study carried out to evaluate ...
- PharmaLive.com (press release),
Genentech Halts Clinical Trial for Drug Jan 18, 2006
...has stopped a clinical trial of a promising peanut-allergy treatment because of safety concerns raised during the human experiments, a company spokesman said ...
- MSN Money
InSite clinical trial continues Jan 13, 2006
Alameda-based InSite Vision Inc. (ISV), a maker of eye treatment products, is done enrolling patients in the second of two clinical ...
- San Jose Mercury News,
Clinical Trial on Gene Therapy for Macular Degeneration Published ... Jan 17, 2006
...when injected directly into the eyes of patients with neovascular age-related macular degeneration, according to the results of a phase I clinical trial to be ...
- Genetic Engineering News,
Arteriocyte Initiates Phase One Clinical Trial with $1.4 Million ... Jan 19, 2006
...developing proprietary stem cell-based therapies for the treatment of vascular diseases, announced it has initiated its Phase I clinical trial to evaluate the ...
- Genetic Engineering News,
Local cancer centers starts new clinical trial Jan 18, 2006
Cancer Centers of Florida is now participating in a breakthrough study on metastatic colorectal cancer with a trial that combines a chemotherapy treatment with ...
- Orlando Business Journal,
Phosphagenics announces successful results from a Phase Ib ... Jan 18, 2006
ASX:POH) and AIM (AIM:PSG) listed pharmaceutical and nutraceutical company, today announces successful completion of the Phase Ib clinical trial of its ...
- PharmaLive.com (press release),
Proacta Inc Announces Phase I Clinical Trial of Novel Prodrug to ... Jan 24, 2006
SAN DIEGO--(BUSINESS WIRE)--Jan. 24, 2006--Proacta Inc, an early stage biotechnology company, announced today that cancer patient ...
- Business Wire (press release),
Roche Plans Clinical Trial With MorphoSys-Generated Alzheimer ... Jan 24, 2006
Standard Segment; TecDAX) announced today that its partner Roche has filed all necessary applications to commence a European Phase 1 clinical trial with a HuCAL ...
- Market Wire (press release)
Halozyme completes enrollment in clinical trial Jan 24, 2006
...(AMEX: HTI, News) reported Tuesday it has completed enrollment of a clinical trial of subcutaneous (SC) hydration (hypodermoclysis) with Hylenex. ...
- San Diego Daily Transcript (subscription),
Proacta conducting clinical trial on cancer treatment Jan 24, 2006
La Jolla-based Proacta Inc, an early stage biotechnology company, announced Tuesday that cancer patient treatment is underway in its Phase I study of PR-104, a ...
- San Diego Daily Transcript (subscription),
Tapestry Initiates Second Phase I Clinical Trial for TPI 287 Jan 10, 2006
...(Nasdaq: TPPH) announced today that it has initiated the treatment of patients in a second Phase I clinical trial for TPI 287, a proprietary third generation ...
- PR Newswire (press release),
Spherix Chooses ENVIRON to Assist With Diabetes Clinical Trial Jan 10, 2006
Nasdaq: SPEX) today announced that it has retained the services of ENVIRON International to help plan and oversee a Phase 3 clinical trial into the use of ...
- PR Newswire (press release),
Ecopia Announces Filing of Clinical Trial Application for ECO-4601 Jan 3, 2006
3, 2006) - Ecopia BioSciences Inc. (TSX:EIA) announces it has filed at the end of the day on Friday, December 30, 2005 a Clinical Trial Application (CTA) for ...
- CCNMatthews (press release),
Avalon Pharmaceuticals Initiates AVN944 Phase I Clinical Trial in ... Jan 9, 2006
...company focused on the discovery and development of small molecule therapeutics, today announced the initiation of a Phase I clinical trial of AVN944 in ...
- PR Newswire (press release),
Xanthus Initiates Phase 2 Clinical Trial with Symadex in Women ... Jan 3, 2006
Sciences, Inc., a privately-held oncology drug development company, today announced that it has begun dosing patients in a Phase 2 clinical trial with Symadex ...
- PR Newswire (press release),
MCRI Granted FDA Approval to Conduct Reduced Anticoagulation ... Jan 10, 2006
LLC (MCRI ™ ) today announced the US Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) clinical trial of the On-X ...
- dBusinessNews Houston (press release),
Neurotech Initiates a Phase II Clinical Trial of NT-501 for the ... Jan 5, 2006
...in the development of sight-saving innovative therapeutics for chronic retinal diseases, announced today the initiation of a Phase II clinical trial of NT-501 ...
- Yahoo! News (press release)
Infinity Initiates Phase I Clinical Trial of IPI-504 for Patients ... Jan 10, 2006
...today announced the initiation of a second Phase I clinical trial of IPI-504, the company's Heat Shock Protein 90 (Hsp90) inhibitor and lead investigational ...
- PR Newswire (press release),
Sunesis Pharmaceuticals Initiates Phase II Clinical Trial of SNS ... Jan 4, 2006
...(Nasdaq: SNSS) today announced that patient treatment has commenced in a Phase II clinical trial of SNS-595, the company's lead anti-cancer therapeutic, in ...
- PR Newswire (press release),
Xanthus launches human clinical trial for breast cancer treatment Jan 3, 2006
Xanthus Life Sciences Inc. has launched a midstage human clinical trial to treat women with metastatic breast cancer. The dosing ...
- Boston Business Journal,
Sangamo BioSciences Announces Plans for Phase 2 Clinical Trial of ... Jan 12, 2006
12 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO - News) today announced that it will outline plans for a Phase 2 clinical trial of SB-509 ...
- Yahoo! News (press release)
U. of Rochester Initiates Phase 2 Clinical Trial of Insmed's iPlex ... Jan 4, 2006
We are very pleased that NIH has endorsed Dr. Moxley's protocol and that NIH and MDA are supporting this important clinical trial. ...
- Genetic Engineering News,
King Pharmaceuticals Commences Phase III Clinical Trial Evaluating ... Jan 5, 2006
...(NYSE: KG) announced today the commencement of the Company's pivotal Phase III clinical trial program evaluating its investigational drug Vanquix(R) as a ...
- PR Newswire (press release),
Threshold Pharmaceuticals Announces Positive Phase 1 Clinical ... Jan 11, 2006
Such forward-looking statements include statements regarding Threshold's product candidates, clinical trials and results, clinical trial plans and potential ...
- Market Wire (press release)
Depomed Announces Positive Results of Phase II Clinical Trial for ... Jan 4, 2006
MENLO PARK, Calif.--(BUSINESS WIRE)--Jan. 4, 2006 - Depomed, Inc. (Nasdaq:DEPO) today announced statistically significant safety ...
- PharmaLive.com (press release),
Depomed Announces Positive Results of Phase II Clinical Trial for ... Jan 4, 2006
Depomed, Inc. (Nasdaq:DEPO) today announced statistically significant safety and efficacy benefits of its Gabapentin GR extended ...
- Genetic Engineering News,
King Pharmaceuticals Initiates Phase II Clinical Trial Evaluating ... Jan 5, 2006
...(NYSE: KG) announced today that it has initiated the Company's Phase II clinical trial program evaluating the safety and efficacy of its topical ...
- PR Newswire (press release),
Antares Completes the Phase II Clinical Trial for Anturol(TM) Jan 3, 2006
Oxybutynin Gel for Overactive Bladder EXTON, Pa., Jan. 3 /PRNewswire-FirstCall/ -- Antares Pharma, Inc. (Amex: AIS) today announced ...
- PR Newswire (press release),
Antares Completes the Phase II Clinical Trial for Anturol Jan 3, 2006
EXTON, Pa., January 03, 2006 /PRNewswire-FirstCall/ -- Antares Pharma, Inc. today announced that it has completed its Phase II clinical ...
- PharmaLive.com (press release),
Clinical Trial to Test Stem Cells for Pediatric Brain Injuries Dec 28, 2005
The phase I clinical trial of 10 patients, ages 5 to 14, will build on previous laboratory and animal research that indicated that bone marrow-derived stem ...
- HealthCentral.com
More Clinical Trial Information Available on Federal Web Site, But ... Jan 3, 2006
Pharmaceutical companies are providing more required information about clinical trials on a federal Web site but are withholding the names of drugs being ...
- Kaiser network.org,
Depomed reports positive clinical trial Jan 4, 2006
Depomed Inc. reported positive results on Wednesday from clinical trials of a treatment for nerve damage from a shingles, or herpes zoster, viral infection. ...
- San Jose Business Journal,
CytRx to Expand Trial in AML Jan 27, 2006
CytRx Corporation has submitted a protocol to the FDA detailing its plans to expand its ongoing phase II clinical trial evaluating its investigational drug ...
- International News Service,
Most extensive thromboembolic disease clinical trial program ... Jan 20, 2006
Boehringer Ingelheim announced today the launch of the biggest thromboembolic disease clinical trial program ever. The trials under ...
- News-Ticker.org (Pressemitteilung),
Cardiogenesis Announces FDA Approval for PMC Clinical Trial Jan 19, 2006
Channeling (PMC) procedures, announced today it has received approval from the US Food and Drug Administration (FDA) on the clinical trial protocol for the PMC ...
- PR Newswire (press release),
Array BioPharma Initiates Phase I Clinical Trial for Targeted ... Jan 17, 2006
...(Nasdaq: ARRY) has initiated dosing cancer patients in a Phase I clinical trial for its targeted small molecule anticancer drug ARRY-334543. ...
- PR Newswire (press release),
FDA Clears First Tranzyme Compound for Clinical Trial Jan 10, 2006
RESEARCH TRIANGLE PARK – Tranzyme Pharma is moving into a new phase of development as a company now that its first drug is on its way to a clinical trial. ...
- Local Tech Wire,
Hydromer, Inc. Announces a Successful Clinical Trial on T-HEXX(R) ... Jan 4, 2006
...(OTC BB: HYDI) (BSX: HDO) announces a successful clinical trial on its patented T-HEXX® Dry Teat Protection Sealant ("T-HEXX® Dry"). ...
- Market Wire (press release)
Novo Nordisk outsources clinical trial data management to TCS Jan 10, 2006
Analysts estimate that off-shoring parts of clinical trial management can reap in savings of up to 40 per cent of the current cost of capturing data from ...
- OutSourcing-Pharma.com,
Clinical Trial Tests Artificial Disc Jan 5, 2006
...discs perform. Twenty-five centers in the United States are involved in the clinical trial, including SpineTeamTexas. The study ...
- NBC5i.com,
Smoking and Alcohol Initiation Clinical Trial Recruiting Patients Jan 5, 2006
By Clinicals Trials - US National Library of Medicine. This study evaluates multi-attribute utility, a modification of subjective ...
- Community Dispatch (press release)
BioMS Medical retains ICON for pivotal multiple sclerosis trial Jan 26, 2006
ICON (ICON; NASDAQ: ICLR) as the global clinical research organization (CRO) for the Company's ongoing pivotal phase II/III clinical trial for MBP8298 for the ...
- Biotech Intelligence (press release),
(BW) CDISC Collaborates with FDA and ACRO in Open Forum on ... Jan 27, 2006
...large group of stakeholders within the clinical research enterprise attended an open forum on January 25 entitled "Creating Clinical Trial Efficiencies through ...
- Houston Chronicle,
International HIV/AIDS Trial Finds Continuous Antiretroviral ... Jan 24, 2006
Therefore, a randomized clinical trial was implemented comparing the use of CD4+ cell-guided episodic ART (DC strategy) with continuous ART (VS strategy). ...
- Science Daily (press release)
Clinical Data advances depression program Jan 27, 2006
Clinical Data is starting patient enrollment in a pivotal phase III clinical trial for vilazodone, a novel compound being studied for treatment of depression ...
- Pharmaceutical Business Review
Sutent® Approved for Kidney Cancer Jan 27, 2006
...approval of Sutent. The first clinical trial included 106 patients, and the second trial included 63 patients. All patients had ...
- Cancer Consultants (press release),
Curis Provides Update on Ongoing Basal Cell Carcinoma Phase I ... Jan 23, 2006
...(NASDAQ: CRIS), a therapeutic drug development company, today provided an update on a Phase I clinical trial for the treatment of basal cell carcinoma. ...
- Genetic Engineering News,
Kosan begins testing oral formulation of anticancer drug Jan 26, 2006
The phase I clinical trial of oral KOS-1022 will evaluate the safety, pharmacokinetics, pharmacodynamics, and bioavailability of escalating doses of the drug ...
- Pharmaceutical Business Review
CytRx Expands Ongoing Arimoclomol Phase II Trial for ALS Jan 23, 2006
...that it has submitted a protocol to the FDA reflecting its plans to treat patients in an open-label extension of its ongoing Phase II clinical trial with its ...
- PharmaLive.com (press release),
Drug treats blood disease Jan 26, 2006
Alexion Pharmaceuticals, says that its drug, eculizumab, sharply reduced the need for blood transfusions during a late-stage clinical trial involving patients ...
- International Herald Tribune,
Alexion Pharmaceuticals Reports Positive Phase III Results for ... Jan 26, 2006
SHEPHERD is an open-label, non-placebo-controlled, multi-center clinical trial primarily aimed at generating safety data with eculizumab in a broader ...
- Biotech Intelligence (press release),
Health Canada Approves Clinical Trial For Vancouver AIDS Patients Dec 28, 2005
Health Canada has approved a clinical trial protocol that will allow AIDS patients in Vancouver to use the experimental drugs TMC 114 and TMC 125. ...
- Medical News Today (press release),
Biomira Inc. announces amendment to licensing agreement for BLP25 ... Jan 26, 2006
Merck to Commence Phase 3 Clinical Trial of L-BLP25 in Non-Small Cell Lung Cancer in Mid 2006 Merck to Assume Development Costs and Pay Royalties to Biomira ...
- CNW Telbec (Communiqués de presse),
Design and conduct of clinical trials in Africa Jan 23, 2006
...health professionals, and particularly clinicians who are currently involved in clinical trials, or those who are at the design stage of a clinical trial to be ...
- African News Dimension,
Pharmos Completes Phase I Cannabinor Study Jan 26, 2006
Munich, Germany. The clinical trial material was manufactured in the Company's GMP pilot facility in Rehovot, Israel. In addition ...
- PharmaLive.com (press release),
FDA Backs Novel Drug for Angina Jan 27, 2006
In its most recent clinical trial, patients getting the drug on top of a calcium channel blocker had an average of 3.3 angina events a week, compared with 4.3 ...
- New York Times,
Biotech Drug Said to Be Useful Against a Rare Blood Ailment Jan 25, 2006
In the clinical trial, about half the patients given the drug had stable hemoglobin levels over six months without needing a transfusion, researchers say. ...
- New York Times,
Stroke trial tests drug combo, cooling helmet Jan 26, 2006
...brain. As part of a clinical trial, paramedics will be trained to inject a drug doctors believe helps protect brain cells from dying. ...
- CBC British Columbia (Audio),
XenoPort Announces Results of Second Phase 1 Trial for XP19986 and ... Jan 5, 2006
SANTA CLARA, Calif., Jan. 5 /PRNewswire-FirstCall/ -- XenoPort, Inc. (Nasdaq: XNPT) announced today the results of a second Phase 1 clinical trial of XP19986 ...
- PR Newswire (press release),
Update on Phase 2B dosing trial for obesity drug Jan 23, 2006
23, 2006-The low dose Phase 2B human clinical trial of obesity drug AOD9604, known as the “OPTIONS? study, is proceeding on schedule. ...
- PharmaLive.com (press release),
AP Pharma seeks approval for trial protocol Jan 25, 2006
AP Pharma has submitted a protocol to the FDA for a single pivotal phase III clinical trial with the company's lead product candidate APF530 for the treatment ...
- Pharmaceutical Business Review
The Center for Business Intelligence Announces the Addition of the ... Jan 25, 2006
25 /PRNewswire/ -- The Center for Business Intelligence (CBI) will hold the Clinical Trial Registries and Results Databases conference on April 24 - 25, 2006 ...
- PR Newswire (press release),
Enanta moves to Phase II in trial of pneumonia drug Jan 23, 2006
Enanta Pharmaceuticals has launched a midstage human clinical trial for a compound that would treat a form of pneumonia. The Watertown ...
- Boston Business Journal,
GroPep Starts Phase 1 Infertility Trial Jan 15, 2006
The trial, which will be conducted under the Therapeutic Goods Administration Clinical Trial Notification scheme, was approved by the Royal Adelaide Hospital ...
- Medical News Today (press release),
Corautus angina trial given all clear Jan 27, 2006
A data safety monitoring committee has recommended the continuation of Corautus Genetics phase IIb clinical trial to evaluate the safety and efficacy of its ...
- Pharmaceutical Business Review
Neurologix Announces Appointment of Marc Panoff as Chief Financial ... Jan 25, 2006
...and epilepsy, and its core technology, which it refers to as "NLX," is currently being tested in a Company-sponsored Phase I human clinical trial to treat ...
- Genetic Engineering News,
A Seductively Cheap Growth Stock Jan 24, 2006
That said, SFBC has become the poster child for the clinical trial industry, so shareholders should recognize that the company will be under a microscope and ...
- Motley Fool
Biomira Inc. announces amendment to licensing agreement for BLP25 ... Jan 26, 2006
The results showed that the new formulation of the vaccine to be used in the phase 3 clinical trial program is not different from the previous formulation from ...
- PharmaLive.com (press release),
The Center for Business Intelligence Announces the Addition of the ... Jan 25, 2006
WOBURN, Mass., January 25, 2006 /PRNewswire/ -- The Center for Business Intelligence (CBI) will hold the Clinical Trial Registries and Results Databases ...
- PharmaLive.com (press release),
Fear Steals the Day from Amgen Jan 26, 2006
Analysts were disappointed that Amgen decided to delay releasing interim clinical-trial data on panitumumab, a colon-cancer treatment. ...
- BusinessWeek
Tapestry Initiates Second Phase I Clinical Trial for TPI 287 Jan 10, 2006
...announced today that it has initiated the treatment of patients in a second Phase I clinical trial for TPI 287, a proprietary third generation taxane. ...
- PharmaLive.com (press release),
Ecopia Announces Filing of Clinical Trial Application for ECO-4601 Jan 3, 2006
3, 2006--Ecopia BioSciences Inc. (TSX:EIA) announces it has filed at the end of the day on Friday, December 30, 2005 a Clinical Trial Application (CTA) for ECO ...
- Business Wire (press release),
UPDATE 1-US regulators need fresh trial on Schering agent 23 Nov 2005
FRANKFURT, Nov 23 (Reuters) - US regulators have asked for at least one additional clinical trial before they can approve Schering AG's (SCHG.DE: Quote, Profile ...
- Reuters
BioCryst To Present at the Lazard Capital Markets Annual Life ... 23 Nov 2005
...the Phase IIa and the Phase I pharmacokinetic trial will assist in the design of a planned combination IV and oral Phase IIb pivotal clinical trial in patients ...
- PR Newswire (press release),
Alexion Reports Phase III Results for PRIMO-CABG2 Study 23 Nov 2005
Pharmaceuticals, Inc. (Nasdaq: ALXN) today reported results from its Phase III PRIMO-CABG2 clinical trial with pexelizumab. The ...
- PR Newswire (press release),
Innovative Research Set To Push Boundaries Of Cancer Care 23 Nov 2005
...at the H. Lee Moffitt Cancer Center and Research Institute and the University of South Florida are almost mid-way through a human clinical trial that uses ...
- Science Daily (press release)
Local dealerships help find cure for diabetes 23 Nov 2005
The Iacocca Foundation’s JoinLeeNow initiative is halfway to reaching its goal of funding a clinical trial for a potential cure for type 1 diabetes, a ...
- Rock River Times,
GTx, Inc. to Present at the Lazard Capital Markets Annual Life ... 23 Nov 2005
...toremifene citrate), a selective estrogen receptor modulator, or SERM, in two separate clinical programs in men: (1) a pivotal Phase III clinical trial for the ...
- PR Newswire (press release),
GlycoGenesys, Inc. Comments on 2005 Third Quarter Financial ... 23 Nov 2005
...quarter compared to the same period last year mainly due to lower legal expenses, reduced drug production costs, as well as lower clinical trial expenses and ...
- Genetic Engineering News,
MINISTRY OF SCINECE & TECHNOLOGY HIGHLIGHTS OF LAST ONE YEAR 23 Nov 2005
Recombinant oral vaccine for cholera has completed Phase I&II clinical trial. · The combination rabies vaccine is under animal trials. ...
- Press Information Bureau (press release),
Patient Recruitment Completed for Phase IIa Clinical Trial of ATL ... Nov 22, 2005
22, 2005: Alizyme plc (LSE:AZM) announces the completion of patient recruitment for its Phase IIa clinical trial to evaluate ATL-104 for the treatment of ...
- PharmaLive.com (press release),
CSC's DVC Reaches Milestone in Plague Vaccine Clinical Trial Nov 22, 2005
Computer Sciences Corporation (NYSE: CSC) announced that DVC LLC, a CSC company, has successfully vaccinated all volunteers in a phase 1 clinical trial for its ...
- Medical News Today (press release),
Integrated Clinical Trial Services Awarded Contract With ... Nov 21, 2005
21, 2005 – Integrated Clinical Trial Services (ICTS) has been awarded a contract with GlaxoSmithKline, a world leading research-based pharmaceutical company ...
- PharmaLive.com (press release),
X-Cell Medical Completes Enrollment for Clinical Trial of ETHOS I ... Nov 21, 2005
...announced today that the Company has completed enrollment in its multinational clinical trial to study the safety and effectiveness of the ETHOS I Coronary ...
- Business Wire (press release),
BioSyntech receives OK for clinical trial of cartilage repair ... Nov 16, 2005
LAVAL, Que. (CP) - BioSyntech Inc. has received approval from Health Canada to begin its pivotal clinical trial of a cartilage repair device. ...
- National Post,
CSC's DVC Reaches Milestone in Plague Vaccine Clinical Trial Nov 18, 2005
DVC Completes Vaccinations for All Volunteers in Phase 1 Clinical Trial for Plague Vaccine Candidate EL SEGUNDO, Calif., Nov. 18 ...
- PR Newswire (press release),
Norwood Immunology – Phase II Clinical Trial – Melanoma Cancer ... Nov 16, 2005
Immunology Limited (AIM: NIM), the company focussed on the rejuvenation of the immune system, today announces the commencement of a Phase II clinical trial. ...
- Biotech Intelligence (press release),
Promising Results Reported in First US Clinical Trial ... Nov 16, 2005
...from three major academic medical centers reported promising results gleaned from the initial phase of the first US clinical trial investigating the benefit of ...
- Yahoo! News (press release)
Norwood Immunology - Phase II Clinical Trial - Melanoma Cancer ... Nov 17, 2005
...that its subsidiary, Norwood Immunology Limited (AIM:NIM), a company focussed on the rejuvenation of the immune system, commenced its Phase II clinical trial. ...
- Business Wire (press release),
CSC's DVC Reaches Milestone in Plague Vaccine Clinical Trial Nov 18, 2005
Computer Sciences Corporation today announced that DVC LLC, a CSC company, has successfully vaccinated all volunteers in a phase 1 clinical trial for its ...
- Finanzen.net,
New Clinical Trial in Children with Autism Begins Enrollment Nov 18, 2005
Hardy Healthcare Associates opens clinical trial site in Hingham to research a treatment for gastrointestinal problems in autistic children HINGHAM, Mass., Nov ...
- PR Newswire (press release),
New Clinical Trial in Children with Autism Begins Enrollment Nov 18, 2005
North San Antonio Healthcare Associates opens clinical trial site in San Antonio to research an investigational medicine for gastrointestinal problems in ...
- PR Newswire (press release),
Metabolic’s Phase 1 Clinical Trial Demonstrates Safety and ... Nov 17, 2005
16, 2005--Metabolic Pharmaceutical’s drug for the relief of neuropathic pain has successfully completed a Phase 1 human clinical trial and will now progress ...
- PharmaLive.com (press release),
CABG Medical Announces Update on Clinical Trial Nov 15, 2005
...(NASDAQ: CABG) today announced the completion of enrollment in the first arm of its international clinical trial of the Holly Graft(TM) System (HGS), a drug ...
- PR Newswire (press release),
ARIAD Announces Initial Results of Phase 1b Clinical Trial of Oral ... Nov 17, 2005
...ability to successfully enroll and conduct preclinical and clinical studies of product candidates, risks and uncertainties that clinical trial results, such as ...
- Business Wire (press release),
Seattle Genetics Initiates SGN-33 Clinical Trial Nov 17, 2005
Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that it has initiated a phase I clinical trial of SGN-33, a humanized anti-CD33 monoclonal antibody, for ...
- Business Wire (press release),
EntreMed Presents Panzem(R) NCD Phase Ib Clinical Trial Results Nov 16, 2005
ROCKVILLE, Md., Nov. 16 /PRNewswire-FirstCall/ -- EntreMed, Inc. (NASDAQ:ENMD), a clinical-stage pharmaceutical company developing ...
- Biotech Intelligence (press release),
New Clinical Trial in Children With Autism Begins Enrollment Nov 18, 2005
WPIC to Study the Effect of an Investigational Drug on Gastrointestinal Problems In Autistic Children PITTSBURGH, Nov. 18 /PRNewswire ...
- PR Newswire (press release),
EntreMed Presents Panzem NCD Phase Ib Clinical Trial Results Nov 16, 2005
ROCKVILLE, Md., November 16, 2005 /PRNewswire-FirstCall/ -- EntreMed, Inc. , a clinical-stage pharmaceutical company developing ...
- PharmaLive.com (press release),
EntreMed Presents Panzem(R) NCD Phase Ib Clinical Trial Results Nov 16, 2005
Pharmacokinetic Goals Achieved in Two Clinical Trials ROCKVILLE, Md., Nov. 16 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD ...
- PR Newswire (press release),
48-Week Clinical Trial Data Provides Information Regarding ... Nov 18, 2005
DUBLIN, Ireland, Nov. 18 /PRNewswire-FirstCall/ -- In a 48-week study presented today at the Tenth European AIDS Conference (EACS ...
- Yahoo! News (press release)
Ascenta AT-101 Clinical Trial Data Presented at the AACR-NCI-EORTC ... Nov 18, 2005
SAN DIEGO, Nov. 18 /PRNewswire/ -- Ascenta Therapeutics Inc., a privately-held clinical stage biopharmaceutical company today announced ...
- PR Newswire (press release),
Data From Phase 1 Clinical Trial of PDX (Pralatrexate) to be ... Nov 16, 2005
WESTMINSTER, Colo., Nov. 16 /PRNewswire-FirstCall/ -- Allos Therapeutics, Inc. (NASDAQ: ALTH) today announced that preliminary data ...
- PR Newswire (press release),
Ascenta AT-101 Clinical Trial Data Presented at the AACR-NCI-EORTC ... Nov 18, 2005
SAN DIEGO, November 18, 2005 /PRNewswire/ -- Ascenta Therapeutics Inc., a privately-held clinical stage biopharmaceutical company today announced the ...
- PharmaLive.com (press release),
Adherex sets clinical trial timetable for cancer drug Nov 16, 2005
Adherex Technologies said Wednesday that it plans to start phase III clinical testing by mid 2007 on a drug it licensed earlier this year from GlaxoSmithKline. ...
- Raleigh Triangle Business Journal,
48-Week Clinical Trial Data Provides Information Regarding ... Nov 18, 2005
DUBLIN, Ireland, Nov 18, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- In a 48-week study presented today at the Tenth European AIDS Conference (EACS ...
- Biotech Intelligence (press release),
SA research group tapped to conduct clinical trial on autism Nov 18, 2005
North San Antonio Healthcare Associates has been named one of 12 research centers nationwide to study an investigational drug in the treatment of ...
- San Antonio Business Journal,
Large Scale Clinical Trial MEGA Study Employing the Hyperlipidemia ... Nov 17, 2005
TOKYO, November 17, 2005 - DAIICHI SANKYO COMPANY, LIMITED presented the results of the large scale clinical trial "MEGA Study" which employs Mevalotin(generic ...
- PharmaLive.com (press release),
Data From Phase 1 Clinical Trial of PDX (Pralatrexate) to be ... Nov 16, 2005
WESTMINSTER, Colo., November 16, 2005 /PRNewswire-FirstCall/ -- Allos Therapeutics, Inc. today announced that preliminary data from ...
- PharmaLive.com (press release),
Predix’s Alzheimer’s treatment passes Ib clinical trial Nov 16, 2005
Predix Pharmaceuticals Inc. yesterday announced the success of Phase Ib clinical trials for its PRX-03140 treatment for mild-to-moderate Alzheimer's disease. ...
- Globes,
Favrille Announces New Data From Phase 2 Clinical Trial of FavId ... Nov 15, 2005
...of cancer, announced today the online publication of its abstract containing long-term follow-up data from the Company's Phase 2 clinical trial of FavId(R ...
- PR Newswire (press release),
InterMune Enrolls 600th Patient in Phase III INSPIRE Clinical ... Nov 9, 2005
...(Nasdaq: ITMN - News) today announced that it has enrolled the 600th patient in its pivotal Phase III INSPIRE clinical trial almost two months ahead of schedule ...
- Yahoo! News (press release)
Guidant Completes Enrollment in International Drug Eluting Stent ... Nov 10, 2005
Guidant Corporation (NYSE:GDT) today announced that the company has completed enrollment in its SPIRIT II drug eluting stent clinical trial. ...
- Genetic Engineering News,
Predix Pharmaceuticals Announces Positive Findings from First ... Nov 14, 2005
...in brain wave activity in patients with mild-to-moderate Alzheimer's disease and was well-tolerated in a recently completed 14-day Phase Ib clinical trial. ...
- Business Wire (press release),
Clinical-trial drug offers hope Nov 14, 2005
When Marie Harvey signed up to participate in a clinical trial of a new drug for early stage breast cancer, the Hillsborough wife and mother was motivated less ...
- New Brunswick Home News Tribune,
Results of the largest clinical trial in type 2 diabetes patients ... Nov 14, 2005
FIELD confirms fenofibrate produces macrovascular and microvascular benefits in diabetic patients without previous cardiovascular disease although primary ...
- Medical News Today (press release),
Sunesis Pharmaceuticals Initiates Leukemia Clinical Trial Nov 15, 2005
...(Nasdaq: SNSS) today announced that patient treatment has commenced in a Phase I clinical trial of SNS-595, the company's lead anti- cancer small molecule drug ...
- PR Newswire (press release),
Fournier Pharma Announces Results of the Largest Clinical Trial in ... Nov 14, 2005
Results of the largest intervention study ever conducted for the prevention of cardiovascular disease in people with diabetes showed that patients treated with ...
- Juraforum.de,
MethylGene Initiates Phase I/II Clinical Trial with MGCD0103 and ... Nov 14, 2005
MONTREAL, CANADA--(CCNMatthews - Nov. 14, 2005) - MethylGene Inc. (TSX:MYG) a biopharmaceutical company, today announced that it ...
- CCNMatthews (press release),
New malaria vaccine shows promise in early clinical trial Nov 9, 2005
A malaria vaccine remains the most desired tool to combat the worsening malaria epidemic in many developing countries. Pierre Druilhe ...
- Medical News Today (press release),
Xenome Launches MultiCentre Clinical Trial for Severe Cancer Pain Nov 15, 2005
...including specificity and potency, into what we hope to show as essential clinical benefits of improved safety and efficacy in our clinical trial program.". ...
- PharmaLive.com (press release),
Fournier Pharma Announces Results of the Largest Clinical Trial in ... Nov 14, 2005
DALLAS, Texas, November 14/PRNewswire/ -- Results of the largest intervention study ever conducted for the prevention of cardiovascular disease in people with ...
- Biotech Intelligence (press release),
Lorus Announces International Conference Presentation of the ... Nov 15, 2005
...pharmaceutical products and technologies for the management of cancer, today announced the publication in abstract of interim results of a clinical trial of GTI ...
- PharmaLive.com (press release),
Xenome Launches MultiCentre Clinical Trial for Severe Cancer Pain Nov 15, 2005
...specificity and potency, into what we hope to show as essential clinical benefits of improved safety and efficacy in our clinical trial program." Hundreds of ...
- PR Newswire (press release),
TorreyPines Therapeutics Initiates Phase I Clinical Trial for ... Nov 14, 2005
...today announced that it has initiated a Phase I clinical trial for NGX424, a novel therapeutic for the treatment of severe migraine and other persistent ...
- Yahoo! News (press release)
Argos Therapeutics and DC Bio Corp. Announce New Clinical Trial to ... Nov 8, 2005
Immunotherapy pioneer Argos Therapeutics in conjunction with Toronto-based DC Bio Corp., announced that a clinical trial for chronic lymphocytic leukemia (CLL ...
- Genetic Engineering News,
Argos Therapeutics and DC Bio Corp. Announce New Clinical Trial to ... Nov 8, 2005
WIRE)--Nov 8, 2005 - Immunotherapy pioneer Argos Therapeutics in conjunction with Toronto-based DC Bio Corp., announced that a clinical trial for chronic ...
- PharmaLive.com (press release),
MethylGene Initiates Phase I/II Clinical Trial with MGCD0103 and ... Nov 14, 2005
MONTREAL--(BUSINESS WIRE)--Nov 14, 2005 - MethylGene Inc. (TSX:MYG) a biopharmaceutical company, today announced that it has initiated ...
- PharmaLive.com (press release),
Animi-3(R) Clinical Trial for Cardiovascular Risk Reduction and ... Nov 8, 2005
...(http://www.pbmpharmaceuticals.com), the maker of Animi-3®, announced today that it is conducting a clinical trial for cardiovascular risk reduction and ...
- Yahoo! News (press release)
Oncolytics Biotech Inc. to Webcast Clinical Trial Update for ... Nov 13, 2005
...(TSX: ONC, NASDAQ: ONCY), will host a webcast at 8:30 am EST on Thursday, November 17, 2005 to provide a clinical trial update for REOLYSIN(R), with a ...
- PR Newswire (press release),
SmartPill Completes Clinical Trial of Its GI Monitoring System ... Nov 8, 2005
...pH.p Capsule, a non-invasive medical device that captures biomedical data from within a patient's GI tract, today announced that the clinical trial of its ...
- Genetic Engineering News,
Generex Biotechnology to Present Clinical Trial Results at the ... Nov 8, 2005
11/08/2005 -- Generex Biotechnology Corporation (NASDAQ: GNBT), a leader in the area of buccal drug delivery, today announced that clinical trial results in ...
- Market Wire (press release)
Boston Scientific Announces Start of Clinical Trial Assessing ... Nov 10, 2005
Pivotal study to assess occipital nerve stimulation using the Precision(R) implantable neurostimulator as a treatment for refractory migraine headache NATICK ...
- PR Newswire (press release),
Boston Scientific Announces Start of Clinical Trial Assessing ... Nov 10, 2005
NATICK, Mass., Nov. 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced that it has received approval ...
- Biotech Intelligence (press release),
Callisto Anti-Cancer Drug Atiprimod Selected for Oral Presentation ... Nov 22, 2005
...developer of new drug technologies in the fight against cancer and other serious healthcare threats, today announced that its first human clinical trial of its ...
- Genetic Engineering News,
Puzzling clinical trial results dull Nabi's luster Nov 14, 2005
...was considered by many to be the crown jewel of Florida biotechnology companies, but the baffling failure of its most crucial clinical trial has halted, and ...
- MSNBC
VirtualScopics to Provide Imaging Services to BioSyntech for ... Nov 22, 2005
...(OTC Bulletin Board: VSCP) announced today that it has agreed with BioSyntech, Inc., a Canadian biotechnology company, to assist in its clinical trial for BST ...
- PR Newswire (press release),
Androclus Therapeutics Reports Completion Of A Phase 2 Clinical ... Nov 8, 2005
2, 2005--Androclus Therapeutics announced the completion of a Phase II clinical trial of AT-001 (dnaJP1), a novel orally administered therapeutic candidate for ...
- Biotech Intelligence (press release),
Alizyme Successfully Completes Clinical Trial for Cetilistat in ... Nov 9, 2005
CAMBRIDGE, England, November 9, 2005 - Alizyme plc (LSE:AZM) has successfully completed its pharmacokinetic/pharmacodynamic clinical trial of cetilistat in ...
- PharmaLive.com (press release),
Malaria vaccine shows promise in early clinical trial Nov 12, 2005
Pierre Druilhe and colleagues, from the Institut Pasteur in Paris, have completed the first human trial of a malaria vaccine based on MSP3, a protein present ...
- Xagena.it,
Malaria Vaccine Proves Effective in Clinical Trial Nov 8, 2005
A new vaccine stimulated human immune cells to recognize and kill malaria parasites in a recent clinical trial. The vaccine proved ...
- Scientific American
Reliance Life Sciences to start clinical trial of Relivax-DC Nov 8, 2005
...for treatment of prostrate cancer soon. "We have finished the pre-clinical trial evaluations of Relivax-DC. Very soon we would be ...
- Hindu Business Line,
Phase 2 Clinical Trial for OT-551 in Cataract Prevention, Othera ... Nov 13, 2005
Pharmaceuticals, Inc., a specialty pharmaceuticals company focused on treating eye disease, announced that it has initiated a Phase 2 clinical trial of its ...
- Medical News Today (press release),
Emergent Suicidality in a Clinical Psychotherapy Trial for ... Nov 13, 2005
OBJECTIVE: The authors’ goal was to examine the incidence and predictors of emergent suicidality that occurred during a clinical trial of psychotherapy for ...
- Am J Psychiatry (subscription)
Boston Scientific to begin migraine clinical trial Nov 11, 2005
Boston Scientific Corp. of Natick has received approval from the Food and Drug Administration to begin a pivotal trial to evaluate ...
- Salem News,
Androgen Deprivation Before and During Radiation Improves Outcomes ... Nov 22, 2005
Researchers from Australia recently conducted a large clinical trial to evaluate androgen deprivation therapy in the treatment of locally advanced prostate ...
- Cancer Consultants (press release),
Sex selection clinical trial is launched Oct 26, 2005
26 (UPI) -- US physicians have reportedly started a clinical trial to assess the effects of allowing couples to choose the gender of unborn children. ...
- Science Daily (press release)
Human Genome Sciences Reports Results of Phase 2 Clinical Trial of ... Nov 1, 2005
1 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI - News) announced today that the results of a Phase 2 clinical trial demonstrate that HGS ...
- Yahoo! News (press release)
Human Genome Sciences Reports Results of Phase 2 Clinical Trial of ... Nov 1, 2005
...announced today that the results of a Phase 2 clinical trial demonstrate that HGS-ETR1 (mapatumumab) is well tolerated and can be administered safely in ...
- PR Newswire (press release),
Dynavax Initiates US-Based Phase 1 Clinical Trial of HEPLISAV ... Nov 1, 2005
BERKELEY, Calif., November 01, 2005 /PRNewswire-FirstCall/ -- Dynavax Technologies Corporation announced the initiation of a Phase 1 clinical trial of HEPLISAV ...
- PharmaLive.com (press release),
Dynavax Initiates US-Based Phase 1 Clinical Trial of HEPLISAV(TM) ... Nov 1, 2005
1 /PRNewswire-FirstCall/ -- Dynavax Technologies Corporation (Nasdaq: DVAX - News) announced the initiation of a Phase 1 clinical trial of HEPLISAV, its ISS ...
- Yahoo! News (press release)
Promising Data From Phase I Trial of Exelixis' XL880 Presented at ... Nov 15, 2005
...covers cancer and metabolism and is comprised of the following compounds: XL119 (becatecarin), for which a multinational Phase 3 clinical trial in bile duct ...
- PR Newswire (press release),
Patient Enrollment Permanently Discontinued in Investigational ... Oct 28, 2005
Approximately 150 clinical trial sites participated in the AbESTT-II worldwide trial, which began in 2003. The goal for enrollment was 1,800 participants. ...
- PR Newswire (press release),
Electronic health record-based clinical trial alert system ... Oct 24, 2005
By Archives of Internal Medicine, An electronic health record-based clinical trial alert system increased recruitment rates and physicians' participation in an ...
- RxPG NEWS,
New technology could improve clinical trial recruitment Oct 25, 2005
...way to prevent medical errors, but researchers are reporting that this new technology may also be just what the doctor ordered for clinical trial recruitment. ...
- Innovations-Report,
Alert System Associated with Increased Clinical Trial Recruitment Oct 24, 2005
Newswise — An electronic health record-based clinical trial alert system increased recruitment rates and physicians’ participation in an ongoing clinical ...
- Newswise (press release)
XenoPort Initiates a Phase 2a Clinical Trial of XP19986 as a ... Oct 26, 2005
...(Nasdaq: XNPT - News) announced today that it has initiated a Phase 2a clinical trial of XP19986 in patients with gastroesophageal reflux disease, or GERD. ...
- Yahoo! News (press release)
SHIRE PRESENTS POSITIVE RESULTS OF HUNTER SYNDROME PIVOTAL ... Oct 28, 2005
SHPGY, TSX: SHQ) announced today at the Annual Meeting of The American Society of Human Genetics, further results of its pivotal clinical trial evaluating its ...
- ITNews,
Osiris Reaches Safety Milestone in Stem Cell Clinical Trial for ... Nov 4, 2005
The Data Safety Monitoring Board is made up of independent physicians, a statistician, an ethicist and a clinical trial specialist. ...
- PR Web (press release),
Tanox Reports Positive Results From Phase 2 Clinical Trial of TNX ... Oct 26, 2005
Research, Division of Infectious and Tropical Diseases at the University of South Florida in Tampa and an investigator in the Phase 2 clinical trial of TNX-355 ...
- PR Newswire (press release),
Preliminary Results from the Estracure Phase II Clinical Trial Oct 28, 2005
Scientific Officer of Estracure, Inc., announced at the Canadian Cardiovascular Congress the results of the Estracure Phase II clinical trial involving 299 ...
- CCNMatthews (Communiqués de presse),
Phase 1a Clinical Trial of XTL-6865 for the Treatment of Hepatitis ... 02 Oct 2005
XTL Biopharmaceuticals Ltd announced that it has initiated the Phase1a clinical trial of XTL-6865 for the treatment of hepatitis C ("HCV"). ...
- Medical News Today (press release)
Forever Living Products announces positive results of UK’s first ... 02 Oct 2005
He said,. “I feel this is a ground breaking piece of research as it is the first randomised, placebo controlled, clinical trial to evaluate a herbal approach ...
- Pressbox.co.uk (press release)
Beware the hype on antipsychotic drugs 02 Oct 2005
...in the United States. It involved an 18-month clinical trial involving 1,400 adults from around the nation. The trial, called the ...
- The Japan Times
A baby-step closer to freezing eggs 02 Oct 2005
Using a freezing technology borrowed from sea creatures, Boston IVF is launching the kind of large, carefully run clinical trial that specialists say is just ...
- Boston Globe
Regadenoson Phase 3 Data Presented as Late-Breaker at American ... 02 Oct 2005
...announced today that Phase 3 study data, presented as a Late Breaking Clinical Trial at the American Society of Nuclear Cardiology Scientific Sessions 2005 in ...
- Yahoo! News (press release)
Fruit that's passed up may slow cancer growth 02 Oct 2005
Pomegranate extract would be a good compound to study in a human clinical trial, said Parnes, chief of the prostate and urologic cancer research group in the ...
- Indianapolis Star
FTY720 Phase II 12-month data show sustained benefits and good ... 02 Oct 2005
...management's expectations regarding commercialization of FTY720 could be affected by, among other things, unexpected clinical trial results; unexpected ...
- Biotech Intelligence (press release)
XenoPort is poised for growth after IPO 02 Oct 2005
...off-patent drugs into new and improved versions, just pulled in $46 million in an initial public offering and released positive clinical trial results. ...
- San Jose Business Journal
Clinical trial to study new option for treatment of lower back ... Oct 1, 2005
Abbott today announced that it has started enrolling patients in a new US clinical study to evaluate the potential benefits of its Wallis® Mechanical ...
- Medical News Today (press release)
NCI and 10 Other Institutions Launch Ovarian Cancer Clinical Trial Sep 29, 2005
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), is leading a clinical trial designed to build a repository of blood ...
- National Institutes of Health (press release)
CSI Announces IDE Approval to Begin Clinical Trial of Its Orbital ... Sep 29, 2005
The conditional approval allows CSI to begin its clinical trial of its Orbital Atherectomy System for treatment of peripheral artery disease at two sites. ...
- PR Newswire (press release)
XTLbio has Initiated the Phase 1a Clinical Trial of XTL-6865 for ... Sep 29, 2005
September 29, 2005 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd ("XTLbio") today announced that it has initiated the Phase1a clinical trial of XTL-6865 ...
- PharmaLive.com (press release)
XTLbio has Initiated the Phase 1a Clinical Trial of XTL-6865 for ... Sep 29, 2005
PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd ("XTLbio") (LSE: XTL ; NASDAQ: XTLB) today announced that it has initiated the Phase1a clinical trial of XTL ...
- PR Newswire (press release)
Weight sorters suit clinical trial batches Sep 29, 2005
The new range includes floor standing units with hoppers for production and clinical trial batches, as well as a bench top model suitable for smaller R and D ...
- Laboratory Talk
Celgene cancer drug clinical trial suspended - WSJ Sep 27, 2005
NEW YORK (Reuters) - A clinical trial of Celgene Corp.'s experimental cancer drug, Revlimid, has been suspended because of concerns about blood clots, the Wall ...
- Reuters
Neurologix announces positive results of gene therapy clinical ... Sep 25, 2005
...(OTCBB:NRGX) today announced positive interim results of its landmark gene therapy clinical trial for patients with Parkinson's disease. ...
- EurekAlert
CuraGen and TopoTarget Initiate Phase Ib Clinical Trial with ... Sep 27, 2005
Stock Exchange: TOPO) announced today the initiation of patient dosing in a Phase Ib open-label, multi-center, proof-of-concept clinical trial evaluating PXD101 ...
- PR Newswire (press release)
Clinical trial participants may not be as unrepresentative of ... Sep 26, 2005
University of Sussex, investigated the hypothesis: is it appropriate to transfer trial findings to routine practice, given that clinical trial volunteers may ...
- News-Medical.net
NASH Clinical Research Network Launches Trial for Treatment of ... Sep 27, 2005
The Nonalcoholic Steatohepatitis (NASH) Clinical Research Network has launched its second clinical trial to study NASH, a liver disease that resembles ...
- WebWire (press release)
Abbott Initiates Clinical Trial to Study New Option for Treatment ... Sep 28, 2005
Doctors Complete First US Spine Surgeries Using Investigational Wallis(R) Device AUSTIN, Texas, Sept. 28 /PRNewswire-FirstCall/ -- Abbott ...
- PR Newswire (press release)
Sonus launches key breast cancer clinical trial Sep 28, 2005
...said it is ready to enroll patients in a phase 3 clinical trial of Tocosol Paclitaxel on which the company will base its marketing approval application with ...
- Puget Sound Business Journal
Osteologix Successfully Completes Phase I Clinical Trial of Novel ... Sep 28, 2005
28 /PRNewswire/ -- Osteologix Inc. today announced that it has completed a Phase I clinical trial of its novel compound NBS-101 to treat osteoporosis. ...
- PR Newswire (press release)
Positive results for UK Clinical Trial Amendment for prostate ... Sep 28, 2005
...(TSX: PBP) announced today that it has completed the continuation through an amendment to the PCK3145-UK-2001 Phase IIa clinical trial in which the feasibility ...
- PR Newswire (press release)
Viron Therapeutics Initiates Phase 2 Clinical Trial of Novel Anti ... Sep 27, 2005
26 /CNW/ - Viron Therapeutics Inc., a drug development company, announced today the initiation of its first Phase 2 clinical trial with its lead anti ...
- CNW Telbec (Communiqués de presse)
ChemGenex Personalized Medicine Clinical Trial Expanded to ... Sep 26, 2005
26 /PRNewswire-FirstCall/ -- ChemGenex Pharmaceuticals Limited (Nasdaq: CXSP; ASX: CXS) today announced that the Phase 2 clinical trial of its investigational ...
- PR Newswire (press release)
AVI BioPharma Initiates Hepatitis C Clinical Trial Sep 28, 2005
Nasdaq:AVII), today announced the initiation of an exploratory safety and efficacy clinical trial using its proprietary NEUGENE(R) antisense compound AVI-4065. ...
- Business Wire (press release)
Achieving Clinical Trial Success: Choosing and Retaining Most ... Sep 26, 2005
Given this enormous economic potential, leading pharmaceutical companies have sought ways to improve the communication of the clinical trial benefits to ...
- PR Newswire (press release)
Immune Response opens clinical trial in Italy Sep 27, 2005
By BRAD SERAPHIN, The Daily Transcript. The Immune Response Corp. (Nasdaq: IMNR, News) announced Tuesday it will begin enrolling ...
- San Diego Daily Transcript (subscription)
CollaGenex Pharmaceuticals Initiates Phase 2 Clinical Trial to ... Sep 26, 2005
...(Nasdaq:CGPI) today announced that it has initiated a Phase 2, double-blinded, placebo-controlled, dose-finding clinical trial to evaluate the safety and ...
- Business Wire (press release)
(PRN) - Positive results for UK Clinical Trial Amendment for ... Sep 28, 2005
...(PRN) - Global Positioning System Navigation Shows Greatest Potential as Next "Breakout" Wireless Handset Application for Americans, According to New Ipsos ...
- Bolsamania.com
Cambridge University instant Chlamydia test clinical trial at ... Sep 25, 2005
Brook in Birmingham (UK) have been asked by the Diagnostics Development Unit at the University of Cambridge (UK) to carry out a performance evaluation study ...
- Medical News Today (press release)
Celgene Cancer Drug Clinical Trial Suspended -- WSJ Sep 28, 2005
NEW YORK SEP 28, 2005 (Reuters) - A clinical trial of Celgene Corp.'s experimental cancer drug, Revlimid (lenalidomide), has been suspended because of concerns ...
- Cancerpage.com
Viacell plunges on clinical trial halt Sep 19, 2005
BOSTON (MarketWatch) - Shares of Viacell plunged Monday morning on news that it was suspending a stem-cell clinical trial over safety concerns. ...
- MarketWatch
India's clinical trial sector can surpass IT revenue by 2010 Sep 21, 2005
One of the reasons for the growth of clinical trial sector is the availability of large number of private hospitals in India, he said. ...
- Hindu Business Line
ViaCell Suspends Enrollment in CB001 Phase I Clinical Trial Sep 19, 2005
...today announced that it has suspended enrollment in its Phase I clinical trial of CB001, an investigational cord blood stem cell product for hematopoietic stem ...
- PharmaLive.com (press release)
CytRx Initiates Phase II Clinical Trial With Arimoclomol for ... Sep 22, 2005
...today announced that after receiving notification from the US Food and Drug Administration (FDA) yesterday, it has initiated a Phase II clinical trial with its ...
- PharmaLive.com (press release)
ViaCell Suspends Enrollment in CB001 Phase I Clinical Trial Sep 19, 2005
19 /PRNewswire-FirstCall/ -- ViaCell, Inc. (Nasdaq: VIAC - News) today announced that it has suspended enrollment in its Phase I clinical trial of CB001, an ...
- Yahoo! News (press release)
ViaCell Suspends Enrollment in CB001 Phase I Clinical Trial Sep 19, 2005
Cambridge, MA -- Sept. 19, 2005 -- ViaCell, Inc. (Nasdaq: VIAC) today announced that it has suspended enrollment in its Phase I clinical trial of CB001, an ...
- Hype & Hope
ViaCell suspends enrollment in clinical trial Sep 19, 2005
...of Cambridge has suspended enrollment in its Phase I clinical trial of CB001, an investigational cord blood stem cell product for hematopoietic stem cell ...
- Boston Mass High Tech
Clinical Trial Results Find Digital Mammography Expands Ability to ... Sep 21, 2005
...digital mammograms. Bethesda, MA (PRWEB) September 21, 2005 -- Preliminary results from a large, clinical trial of digital vs. film ...
- PR Web (press release)
UPDATE: Viacell Plunges On Clinical Trial Halt Sep 19, 2005
By Val Brickates Kennedy. BOSTON (Dow Jones) - Shares of Viacell plunged Monday on news that it was suspending a stem-cell clinical trial over safety concerns. ...
- Business Online
Somaxon Pharmaceuticals, Inc. Initiates Second Phase III Clinical ... Sep 20, 2005
...of diseases and disorders in the fields of psychiatry and neurology, today announced that enrollment has begun in the second Phase III clinical trial of SILENOR ...
- Genetic Engineering News
Isotechnika's Phase III psoriasis trial achieves clinical ... Sep 21, 2005
Isotechnika's lead compound, ISA247 is an immunosuppressant currently in a Canadian Phase III human clinical trial for the treatment of moderate to severe ...
- Canada NewsWire (press release)
DOBI Medical International Progresses with ComfortScan(R) PMA ... Sep 21, 2005
...(DBMI.OB) today announced that it has added its twentieth trial site to its pre-market approval (PMA) clinical trial studying its Dynamic Optical Breast ...
- Genetic Engineering News
ViaCell stock plunges on news of suspended clinical trial Sep 19, 2005
...watched its stock price drop close to 20 percent in early trading Monday as investors reacted to the suspension of a clinical trial over adverse side effects. ...
- Boston Business Journal
Clinical Trial Delays Cost Pharmaceutical Companies Sep 20, 2005
According to a new study by Cutting Edge Information, patient recruitment and enrollment challenges are the leading causes of missed clinical trial deadlines. ...
- PR Newswire (press release)
Genaera Initiates Pivotal Phase II Clinical Trial of LOMUCIN(TM) ... Sep 21, 2005
21 /PRNewswire-FirstCall/ -- Genaera Corporation (Nasdaq: GENR) today announced the start of its pivotal Phase II clinical trial for the mucoregulator drug ...
- PR Newswire (press release)
Affymax Begins Third Phase 2 Clinical Trial of Hematide(TM) Sep 21, 2005
..."We anticipate that the ongoing Phase 2 clinical trial in CKD patients on dialysis and this new Phase 2 trial in CKD patients not on dialysis will provide ...
- PR Newswire (press release)
Regulators place hold on ViaCell clinical trial Sep 22, 2005
The US Food and Drug Administration has placed a clinical hold on ViaCell Inc.'s clinical trial for an umbilical cord blood stem cell-transplantation treatment ...
- Boston Business Journal
Aethlon Medical Launches Hepatitis-C Clinical Trial Sep 20, 2005
Aethlon Medical, Inc. (OTCBB:AEMD) announced today that human clinical trials to treat patients infected with the Hepatitis-C virus ...
- Genetic Engineering News
ViaCell places hold on clinical trial Sep 22, 2005
...of Cambridge today announced that the Food and Drug Administration has placed a clinical hold on the company’s Phase I clinical trial evaluating CB001, an ...
- Boston Mass High Tech
(PRN) - ViaCell Suspends Enrollment in CB001 Phase I Clinical ... Sep 19, 2005
...(PRN) - Fidelity National Information Services' Hansen Quality Group Adds Fraud Prevention Component to Collateral Risk Tool ... [+. ...
- Bolsamania.com
IFPMA Clinical Trial Portal - One stop shop for clinical trials ... Sep 22, 2005
...found. The other involves clinical trial results, which are made available in a standard summary format by various online databases. ...
- Medical News Today (press release)
Glaxo cuts HIV clinical trial short Sep 21, 2005
After two participants developed sever liver toxicity, GlaxoSmithKline halted a phase III clinical trial meant to test the effectiveness of their new anti ...
- myDNA.com
Emisphere Technologies Completes Dosing in Heparin Clinical Trial Sep 19, 2005
19 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS) today announced that it has completed dosing all arms of a clinical trial to compare ...
- PR Newswire (press release)
Celera Genomics Initiates Phase I Clinical Trial for Cathepsin S ... Sep 20, 2005
ROCKVILLE, Md.--(BUSINESS WIRE)--Sept. 20, 2005--Celera Genomics (NYSE:CRA), an Applera Corporation business, today announced the ...
- Business Wire (press release)
Celera Genomics Initiates Phase I Clinical Trial for Cathepsin S ... Sep 20, 2005
ROCKVILLE, Md.--(BUSINESS WIRE)--Sep 20, 2005 - Celera Genomics (NYSE:CRA), an Applera Corporation business, today announced the initiation of Phase I clinical ...
- PharmaLive.com (press release)
Generex Biotechnology Clinician To Present Clinical Trial Results ... Sep 20, 2005
...clinical trials of Oral-lyn(TM), its proprietary oral insulin spray product, will make the following presentations of Oral-lyn(TM) clinical trial results at ...
- PR Newswire (press release)
Mistral Pharma Reports Positive Results From Pilot Clinical Trial ... Sep 20, 2005
20, 2005) - Mistral Pharma Inc. (TSX VENTURE:MIP) announced today that the pilot clinical trial of the branded product MIST-B01 showed positive results. ...
- CCNMatthews (Communiqués de presse)
Vyteris Announces Positive Results for Phase I Clinical Trial Sep 20, 2005
FAIR LAWN, NJ, September 20, 2005 /PRNewswire-FirstCall/ -- Vyteris Holdings (Nevada), Inc. announced today data from a Phase I ...
- PharmaLive.com (press release)
Ceregene Reports Initiation of Phase 1 Clinical Trial of Novel ... Sep 21, 2005
SAN DIEGO, Sept. 21 /PRNewswire-FirstCall/ -- Ceregene announced today that patient treatment is underway in its Phase I study of ...
- PR Newswire (press release)
Vyteris Announces Positive Results for Phase I Clinical Trial Sep 20, 2005
...- Data indicate Actyve(TM) transdermal drug delivery technology can control rate of zolmitriptan delivery in humans FAIR LAWN, NJ, Sept. ...
- PR Newswire (press release)
Vyteris Announces Positive Results for Phase I Clinical Trial Sep 20, 2005
FAIR LAWN, NJ, Sept. 20 /PRNewswire-FirstCall/ -- Vyteris Holdings (Nevada), Inc. (OTC Bulletin Board: VYHN - News) announced today ...
- Yahoo! News (press release)
Cytomedix Appoints Former FDA Manager to Lead Comprehensive ... Sep 22, 2005
...of diabetic foot ulcers, and has appointed Jennifer Grayson, a former FDA manager, and now consultant, to lead the audit of clinical trial information and data ...
- PrimeZone (press release)
Clinical trial results for new epilepsy treatment Keppra ... Sep 18, 2005
Paediatric clinical trial results of the new epilepsy treatment Keppra (levetiracetam) were reported in Europe for the first time, at this week's meeting of ...
- Medical News Today (press release)
Cytheris launches a new Phase I clinical trial in the US for its ... Sep 19, 2005
PARIS, September 19, 2005 - Cytheris, a biopharmaceutical company focused on immuno-modulation, announced today the start of a fifth Phase I clinical study in ...
- PharmaLive.com (press release)
Novagali Pharma Completes a Phase I Clinical Trial in Oncology ... Sep 19, 2005
...innovative drug delivery systems principally in ophthalmology and oncology, announced today the successful completion of a Phase I clinical trial in patients ...
- PharmaLive.com (press release)
Company growing clinical trial business Sep 20, 2005
...and the risks for heart attacks and strokes. That link came to light through a clinical trial. The death last month of ABC network ...
- Nashville Business Journal
Nutrition Formulators, Inc and HCIS Laboratories To Offer Clinical ... Sep 23, 2005
...nutraceutical laboratory, and HCIS, Miami based clinical laboratory since 1993, have partnered to offer clinical trial services to the nutraceutical industry. ...
- NPIcenter (press release)
ClinPhone addresses key clinical trial issues with upcoming ... Sep 19, 2005
ClinPhone, the global leader in clinical technology solutions, announces the schedule for its upcoming webinar series. ClinPhone ...
- WebitPR (press release)
Clinphone Addresses Key Clinical Trial Issues with Upcoming ... Sep 19, 2005
LONDON, Sept. 19, 2005 - ClinPhone, the global leader in clinical technology solutions, announces the schedule for its upcoming webinar series. ...
- PharmaLive.com (press release)
Phase 1A Clinical Trial with KB2115 Successfully Completed Sep 19, 2005
HUDDINGE, Sweden, Sept. 19, 2005--Karo Bio has completed the first single ascending dose part of its phase 1 study for KB2115 with a successful outcome. ...
- PharmaLive.com (press release)
New cancer treatments reduce serious side effects Oct 1, 2005
Women involved in this clinical trial must have significant solid tumour growth. The clinical trial will not provide any kind of ...
- NorthernLife.ca
Neurochem Announces Launch of European Phase III Clinical Trial on ... Sep 13, 2005
North American Phase III Clinical Trial on Alzhemed(TM) Fully Enrolled ----- LAVAL, Sept. ...
- PR Newswire (press release)
Neurochem Announces Launch of European Phase III Clinical Trial on ... Sep 13, 2005
...announced today that it has launched its European Phase III clinical trial on Alzhemed(TM), following an investigators' meeting attended by more than 250 ...
- PharmaLive.com (press release)
Peplin Limited: Start of US Dose Escalation Clinical Trial Sep 1, 2005
1, 2005: Peplin Limited (ASX:PEP) announced it had initiated its US-based phase IIa clinical trial to study increasing doses of its proprietary product PEP005 ...
- PharmaLive.com (press release)
Should You Join a Clinical Trial? Sep 7, 2005
A crucial step in developing safe and effective treatments for cancer is a clinical trial. Washington, DC - American Institute for ...
- Kansas City infoZine
Cytokinetics Announces the Initiation of a Phase I Clinical Trial ... Sep 6, 2005
6, 2005--Cytokinetics, Incorporated (Nasdaq: CYTK) announced the initiation of a Phase I clinical trial with CK-1827452, a novel, small-molecule activator of ...
- Business Wire (press release)
Cytokinetics Announces the Initiation of a Phase I Clinical Trial ... Sep 6, 2005
SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Sep 6, 2005 - Cytokinetics, Incorporated (Nasdaq: CYTK) announced the initiation of a Phase I clinical trial with CK ...
- PharmaLive.com (press release)
Pharmacyclics Announces Enrollment of Patients in Phase 2 Clinical ... Sep 13, 2005
13 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced that it is enrolling patients in an open-label Phase 2 clinical trial of Xcytrin ...
- PR Newswire (press release)
Pharmacyclics Announces Enrollment of Patients in Phase 2 Clinical ... Sep 13, 2005
...today announced that it is enrolling patients in an open-label Phase 2 clinical trial of Xcytrin(R) (motexafin gadolinium) Injection, the company's lead cancer ...
- PharmaLive.com (press release)
King Pharmaceuticals Reports Publication of HOPE-TOO Clinical ... Sep 6, 2005
BRISTOL, Tenn., Sept. 6 /PRNewswire-FirstCall/ -- King Pharmaceuticals, Inc. (NYSE: KG) today reported the publication of the results ...
- PR Newswire (press release)
King Pharmaceuticals Reports Publication of HOPE-TOO Clinical ... Sep 6, 2005
BRISTOL, Tenn., September 06, 2005 /PRNewswire-FirstCall/ -- King Pharmaceuticals, Inc. today reported the publication of the results ...
- PharmaLive.com (press release)
King Pharmaceuticals Reports Publication of HOPE-TOO Clinical ... Sep 6, 2005
BRISTOL, Tenn., Sept. 6 /PRNewswire-FirstCall/ -- King Pharmaceuticals, Inc. today reported the publication of the results of the ...
- Finanzen.net
Insmed Provides Update on iPlex Pivotal Trial Data in Severe ... Sep 29, 2005
29, 2005--Insmed Incorporated (NASDAQ: INSM) provided an update on its ongoing pivotal clinical trial of iPlex(TM) (rhIGF-1/rhIGFBP-3) (Mecasermin rinfibate ...
- Business Wire (press release)
Cytomedix Announces Preliminary Results of Clinical Trial for ... Sep 12, 2005
ROCKVILLE, Md., Sept. 12, 2005 (PRIMEZONE) -- Cytomedix, Inc. (AMEX:GTF) today announced that preliminary analysis of a clinical trial for its AutoloGel(tm ...
- PharmaLive.com (press release)
Preparing the Market: Communicating Clinical Trial Results to All ... Sep 15, 2005
CHAPEL HILL, NC, Sept. 15 /PRNewswire/ -- Clinical trial results determine the success of pharmaceutical products in the marketplace. ...
- PR Newswire (press release)
Helix receives approval to conduct a clinical trial of Topical ... Sep 12, 2005
...that it has received approval from Sweden's drug regulatory authority, the Medical Products Agency (MPA), to conduct a Phase II clinical trial of Topical ...
- PharmaLive.com (press release)
Progenics Reports Positive Results from Phase 1 Clinical Trial of ... Sep 9, 2005
Dose-dependent binding of PRO 140 to CCR5-expressing cells was reported in the clinical trial, with the highest PRO 140 concentration tested significantly ...
- PharmaLive.com (press release)
VioQuest's Proposed Drug Acquisition Candidate Enters Phase I ... Sep 13, 2005
13, 2005 (PRIMEZONE) -- The Cleveland Clinic Taussig Cancer Center has initiated patient enrollment for a Phase I clinical trial of sodium stibogluconate (SSG ...
- ArriveNet (press release)
Antares Pharma Initiates Phase II Clinical Trial For Its ... Sep 7, 2005
7 /PRNewswire-FirstCall/ -- Antares Pharma, Inc. (Amex: AIS), today announced that it has initiated a Phase II clinical trial of its oxybutynin based, Anturol ...
- PR Newswire (press release)
Cytomedix Issues Statement Regarding Clinical Trial Analysis Sep 13, 2005
D., today issued the following statement concerning the preliminary analysis of a clinical trial regarding the Company's AutoloGel(tm) platelet releasate ...
- PrimeZone (press release)
Hana Biosciences Initiates Clinical Trial for IPdR in Colorectal ... Sep 7, 2005
OTCBB: HNAB), a South San Francisco-based biopharmaceutical company focused on advancing cancer care, has initiated a Phase I IPdR clinical trial in colorectal ...
- PharmaLive.com (press release)
Ondine Biopharma Reports Successful Pilot Clinical Trial Results Sep 14, 2005
This pilot clinical trial was a randomized, controlled study comparing Scaling and Root Planing (SRP) alone to Ondine's adjunctive photodynamic disinfection ...
- Yahoo! News (press release)
PRA to manage clinical trial for Biomira cancer vaccine Sep 16, 2005
PRA International, a clinical research organization, is to manage a global phase III clinical trial of Biomira's BLP25 liposome vaccine for the treatment of non ...
- Pharmaceutical Business Review
GTx reaches agreement with FDA on clinical trial of cancer drug Sep 16, 2005
GTX Inc. has agreed upon a clinical trial design with FDA for the pivotal Phase III trials of Acapodene, a drug to prevent prostate cancer in high-risk men. ...
- Memphis Business Journal
GelStat Corporation Announces Publication of Results from First ... Sep 6, 2005
GSAC), a pioneer in the development and marketing of next-generation OTC pain relievers, today announced that results from the first clinical trial of GelStat ...
- PR Newswire (press release)
Foamix to commence Phase II clinical trial of athlete’s foot ... Sep 12, 2005
Healthcare products start-up Foamix today announced plans to commence a Phase II, placebo-controlled clinical trial of TerbiFoam 2% foam for the treatment of ...
- Globes
InSightec Begins New Clinical Trial Using ExAblate(R) 2000 ... Sep 14, 2005
HAIFA, Israel, September 14 /PRNewswire/ -- InSightec is enrolling patients in a new study evaluating its ExAblate(R) 2000 in the treatment of liver tumours ...
- Finanzen.net
Generex Biotechnology Clinician to Present Clinical Trial Results ... Sep 7, 2005
...on-going clinical trials of Oral-lyn(TM), its proprietary oral insulin spray product, will make a presentation of Oral-lyn(TM) clinical trial results at the ...
- PR Newswire (press release)
This page is updated on a monthly basis if relevant articles are available. If you are looking for further information on
Clinical Trial
you may want to try searching the Internet using the Google search box below.
|
|
|
